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Abstract 
 
Control of B-cell signal transduction is critical to prevent production of pathological 
autoantibodies. Tandem PH domain containing proteins (TAPPs) specifically bind PI(3,4)P2, a 
phosphoinositide product generated by PI 3-kinases and the phosphatase SHIP. TAPP KI mice 
bearing PH domain-inactivating mutations in both TAPP1 and TAPP2 genes, uncoupling them 
from PI(3,4)P2, exhibit increased BCR-induced activation of the kinase Akt and develop lupus-
like characteristics including anti-DNA antibodies and deposition of immune complexes in 
kidneys. Here we find that TAPP KI mice develop chronic germinal centers (GCs) with age and 
show abnormal expression of B cell activation and memory markers. Upon immunization with T-
dependent Ag, TAPP KI mice develop functional but abnormally large GCs, associated with 
increased GC B cell survival.  Disruption of chronic GCs in TAPP KI mice by deletion of the 
costimulatory molecule ICOS abrogate anti-DNA and anti-nuclear antibody production in TAPP 
KI mice, indicating an essential role for GCs. Moreover, TAPP KI B cells are sufficient to drive 
chronic GC responses and recapitulate the autoimmune phenotype in bone marrow chimeric mice. 
Our findings demonstrate a B cell-intrinsic role of TAPP-PI(3,4)P2 interaction in regulating GC 
responses and autoantibody production and suggest that uncontrolled Akt activity in B cells can 
drive autoimmunity. 
  
Introduction 
 
Phosphoinositide 3-kinases (PI3K) play critical roles in B cell activation via their antigen receptor 
(BCR) and other key receptors [1-3]. Class I PI3Ks mediate downstream signaling by 
phosphorylating plasma membrane lipids to generate the phosphoinositide second messengers 
PI(3,4,5)P3 and PI(3,4)P2. The dynamics of these lipid second messengers are tightly regulated 
by PI phosphatases PTEN, INPP4 and SHIP which dephosphorylate the 3, 4 or 5 position of the 
PI headgroup, respectively [4, 5]. PI phosphatases, together with PI3Ks, can thus control the 
plasma membrane localization and function of specific PI-binding signaling proteins that 
collectively determine the downstream response. PI3K plays an essential role in maintaining 
mature B cell survival, which depends on tonic BCR signaling [6, 7]. In B cell malignancies that 
depend on aberrant chronic BCR signaling, blockade of PI3K signaling has been found to be an 
effective therapeutic strategy [1, 8]. 
Dysregulation of the PI3K pathway has been associated with lupus-like autoimmune disease in 
mouse models and in humans. SHIP-/- mice exhibited B cell hyper-responsiveness, splenomegaly 
and abnormally elevated antibody production [9, 10].  SHIP was found to be activated in anergic 
B cells and B cell-specific deletion of SHIP resulted in development of lupus-like phenotype [11].  
B cell-specific deletion of SHIP also resulted in failure to develop tolerance to artificial 
autoantigens in BCR transgenic models [11, 12]. The inhibitory receptor Fc!RIIB functions in part 
through activation of SHIP [13], and polymorphisms in fcgr2b have been linked to lupus in mouse 
models and humans [14-16]. Thus, regulation of phosphoinositide accumulation is critical for 
control of autoreactive B cells and failure to properly control the PI3K pathway can contribute to 
development of autoimmunity. 
B cell proliferation and death in germinal centers (GC) is critical for generation of both protective 
antibodies and pathogenic autoantibodies. Selective survival and expansion of B cells capable of 
producing mutated, high affinity antibody depends on both BCR signaling and Ag presentation to 
follicular helper T cells (Tfh).  The PI3K pathway is known to critical roles in both GC B cell and 
Tfh functions [17]. Genetic disruption of the p110" PI3K leads to a virtual absence of GCs [18, 
19].  The PI3K pathway appears to be highly active within GC B cells based on high levels of 
phosphorylation of the PI3K-dependent kinase Akt [20], which may be important to maintain 
survival of GC B cells by promoting expression of BCL-2 family member Mcl-1 [21]. p110" PI3K 
also plays a role in induction of the key GCB transcriptional regulator BCL6 [22] and can modulate 
expression of the enzyme AID [23] which drives antibody diversification within GC. 
Phosphoinositides mediate their cellular functions by binding to effector proteins containing PI-
binding modules such as PH domains [24, 25]. Well-characterized PI binding proteins functioning 
in B cell activation include the protein kinases Akt and Btk, which have distinct specificity in 
binding PI species. Akt binds with similar affinity to the SHIP substrate PI(3,4,5)P3 and its product 
PI(3,4)P2 [26], while Btk exclusively binds PI(3,4,5)P3 [27]. PI(3,4)P2 binding can activate Akt 
activity in vitro [26, 28]; however its function in vivo remains unclear. Tandem PH domain 
containing adaptor proteins 1 and 2 (TAPP1 and TAPP2) are the best characterized proteins that 
specifically interact with the product of SHIP PI(3,4)P2, but not its substrate PI(3,4,5)P2 [29, 30]. 
Co-engagement of BCR and Fc!RIIB enhances activation of SHIP, leading to more conversion of 
PI(3,4,5)P3 to PI(3,4)P2 [31-33]. Thus SHIP can function to inhibit membrane recruitment of 
PI(3,4,5)P3-binding proteins such as Btk, but can also enhance recruitment of PI(3,4)P2-binding 
proteins such as TAPP1&2 [33]. 
TAPP adaptors contain a unique and well-characterized phosphoinositide binding pocket in their 
C-terminal PH domain [29], which has enabled introduction of mutations that specifically disrupt 
PI(3,4)P2 binding [34]. Mice bearing inactivating mutations in the C-terminal PH domains of both 
TAPP1 and TAPP2 (TAPP KI) were found to develop lupus-like characteristics including 
generation of anti-DNA and anti-nuclear antibodies [35]. In this study, we have explored the 
mechanisms underlying autoimmunity in TAPP KI mice. We find that uncoupling TAPPs from 
PI(3,4)P2 in B cells leads to abnormal germinal centre responses which are critical for driving 
autoantibody production. These findings implicate TAPPs as important regulators of the germinal 
center response which control autoreactive B cells via binding to the phosphoinositide product of 
SHIP. 
  
Results 
Abrogation of TAPP - PI (3,4)P2 interaction results in spontaneous B cell activation and 
chronic GCs 
We previously found that mice bearing inactivating mutations in the PI(3,4)P2-binding PH 
domains of TAPP1 and TAPP2 (TAPP KI) develop a lupus-like autoimmune disease manifesting 
as autoantibody production detectable by 20 weeks of age [35].  To investigate the basis for this 
autoimmune pathology we assessed whether middle aged TAPP KI mice display any abnormalities 
in their B cell populations. At 28-30 weeks of age, TAPP KI splenic B cells exhibited increased 
frequencies of cells expressing germinal centre B cell (GCB) markers GL7 and Fas (Figure 1A 
and Supplementary Figure 1). This elevated frequency of GCB was associated with a proportional 
increase in the PD1+ ICOS+ T follicular helper (Tfh) cell population (Figure 1B).  Flow cytometry 
gating of GCB and Tfh populations was controlled using age-matched mice genetically deficient 
in p110" PI3K activity, which lack these populations [17, 19].  Middle-aged TAPP KI mice also 
showed a significant increase of CD80+ B cells in the spleen and a trend toward elevated CD86 
expression (Figure 1C and Supplementary Figure 2). Similar increases in GCB and CD80+ B cells 
were observed in mesenteric lymph nodes of TAPP KI mice (Figure 1D).  Together these results 
demonstrate that TAPP KI mice develop B cell hyper-activation and chronic GC formation. 
Development of chronic GC in TAPP KI mice is age and gene dose dependent  
Abnormal chronic GCs have been associated with autoimmunity in mice as well as humans [36, 
37]; thus we further examined the kinetics and gene dose dependence of chronic GC development 
in the TAPP KI model.  Increased GCB and Tfh populations were detectable by 12 weeks of age 
and increased over time (Figure 2A/B). Frequencies of GCB and Tfh cells were found to be highly 
sensitive to WT TAPP gene dosage, with heterozygote mice bearing a single normal TAPP1 and 
TAPP2 allele showing GCB and Tfh frequencies similar to controls (Figure 2C/D).  The 
frequencies of CD80+ splenic B cells also showed progressive increase with age (Figure 2E) and 
a similar dependence on WT TAPP gene dosage (Figure 2F), suggesting that generation of this B 
cell population may be related to the chronic GC response. 
Uncoupling of TAPP adaptors from PI(3,4)P2 results in abnormal GC responses upon 
immunization  
To assess the impact of TAPP–PI(3,4)P2 interaction on the GC response induced by immunization, 
8-10 week old TAPP KI mice were immunized with T dependent antigens NP-OVA/alum or sheep 
red blood cells. Flow cytometry analyses revealed that approximately 2 fold increases in the 
frequency of GC B cells in immunized TAPP KI mice (Figure 3A). Immunofluorescence staining 
of spleen sections showed that TAPP KI GCs show no obvious abnormality in structure or 
positioning near the interface of B and T cell zones (Figure 3B and Supplementary Figure 3) but 
have a larger average area. Follicular helper T cell frequencies were correspondingly increased in 
immunized TAPP KI mice (Figure 3C), however the GCB:Tfh ratio was not significantly different 
from controls. TAPP KI mice show no significant difference in generation of high affinity anti-NP 
Abs (Figure 3D), but produced significantly increased levels of polyclonal IgG after immunization 
(Figure 3E).   
TAPP KI B cells were previously found to have a relatively normal response to BCR cross-linking 
in vitro, with the exception of increased phosphorylation of the PI3K-dependant protein kinase 
Akt [35]. We thus further examined the GC B cell population to assess Akt phosphorylation, cell 
division and cell survival.  Akt phosphorylation was examined by flow cytometry and found to be 
significantly elevated within the TAPP KI GCB population (Figure 4A).  GC B cell division was 
examined by pulse BrdU labeling and was not significantly altered (Figure 4B). TAPP KI GC B 
cells did however exhibit significantly increased cell viability ex vivo, based on DAPI and Annexin 
V staining (Figure 4C). Together these results suggested that uncoupling TAPP adaptors from the 
SHIP product PI(3,4)P2 results in abnormal levels of Akt phosphorylation and B cell survival 
within GC, which is is associated with larger GC size and increased production of non-Ag specific 
Abs. 
Ablation of GCs blocks development of autoantibodies in TAPP KI mice  
To investigate the role of chronic GCs in the development of autoantibody-mediated disease in 
TAPP KI mice, ICOS-/- mice [38] were crossed with TAPP KI mice to generate ICOS-/- TAPP KI 
mice or ICOS+/-  TAPP KI mice. Immunization of young adult mice revealed that loss of one ICOS 
allele diminished the GC response in TAPP KI mice to levels comparable to wild-type control 
mice, while deletion of ICOS substantially ablated TAPP KI GC responses (Figure 5A).  
Development of chronic germinal centers in unimmunized middle-age TAPP KI mice showed a 
similar pattern of dependence on ICOS (Figure 5B). ICOS was also required for abnormal 
accumulation of the CD80+ and CD86+ B cell population (Figure 5C/D). Significantly, ICOS-/- 
TAPP KI mice did not show development of anti-dsDNA autoantibodies in the serum with age 
(Figure 5E/F). Anti-nuclear antibodies (Figure 5G) and IgG deposition in kidney (Figure 5H) were 
observed in TAPP KI mice but not in ICOS-/- TAPP KI mice.  These results demonstrate that 
genetic disruption of chronic GC responses in TAPP KI mice impairs development of 
autoimmunity. 
B cell-intrinsic role of TAPP-PI(3,4)P2 interaction in preventing autoantibody production 
TAPP KI B cells were previously shown to be hyper-responsive to BCR cross-linking [35], 
suggesting that B cell-intrinsic signaling defects may underlie abnormal GC responses and 
development of autoantibodies in TAPP KI mice.  We utilized an established mixed bone marrow 
chimera method [39] to reconstitute B cell deficient mice with either wild-type or TAPP KI B cells 
and thus assess whether TAPP KI B cells can drive autoimmune disease in an otherwise normal 
environment.  Wild-type or TAPP KI bone marrow reconstituted the B cell compartment in µmT 
mice to a similar extent (Figure 6A), however circulating TAPP KI B cells showed increased levels 
of CD80 or CD86 within 6 weeks of reconstitution (Figure 6B). Unimmunized TAPP KI B cell 
chimeras developed increased GCB and Tfh populations in the spleen, as well as increased markers 
of chronic B cell activation compared to WT B cell chimeras (Figure 6C). TAPP KI B cell chimeric 
mice also exhibited circulating anti-dsDNA antibodies (Figure 6D), anti-nuclear antibodies 
(Figure 6E) and deposition of IgG in kidney glomeruli (Figure 6F).  Together these results indicate 
that uncoupling TAPP adaptors from PI(3,4)P2 in B cells confers intrinsic hyper-activation 
properties that can drive autoimmune disease.   
  
Discussion 
Autoimmune diseases such as SLE are characterized by chronic GC that are important for 
generation of mutated and class-switched autoantibodies [36, 40]. In TAPP KI mice we have 
detected a progressive increase in GCB cell frequencies with age as well as chronic activation of 
B cells based on increased expression of costimulatory molecules. Abnormal germinal centre 
responses can be driven by defects in either GCB or TFH subsets, which can bi-directionally 
activate each other and contribute to autoimmunity [41, 42]. Ablation of the GC response in TAPP 
KI mice by crossing with ICOS KO mice led to loss of anti-DNA Abs and also normalized the 
frequencies of CD80 or CD86+ cells. This indicates that GCB-TFH interaction is critical for driving 
autoimmunity in this model, but does not resolve whether TAPP mutations in the B or T cell 
compartment is driving the response. Our µmT bone marrow chimera results indicate that 
uncoupling of TAPPs from PI(3,4)P2 in B cells is sufficient to drive chronic GCs (including 
expansion of the TFH population) and recapitulate the autoimmune phenotype of the TAPP KI 
mice. It remains possible that disruption of TAPP function in TFH cells or other immune cell 
populations may contribute to generation of the autoimmune or inflammatory state; this is a 
potential avenue of further investigation. 
GC responses are highly dependent on PI3K signaling as demonstrated by PI3Kδ mutant mice that 
lack germinal centers [18, 19]. While proximal BCR signaling seems to be inhibited within most 
GC B cells, phosphorylation of Akt and its target S6K remains active in GC B cells [20], indicating 
that the PI3K/Akt pathway may have a critical role in GC B cells. Recent evidence indicates that 
PI3K and Akt are most active in the GC light zone and play a role in regulating isotype switch and 
selection of antigen-specific cells [43]. We previously found that TAPP KI B cells show elevated 
phosphorylation of Akt upon activation [35], thus our working hypothesis is that the abnormal GC 
response in TAPP KI mice is a result of uncontrolled activity of Akt. Consistent with this 
hypothesis, we found increased Akt phosphorylation within TAPP KI GC B cells using phosflow 
analysis. Although TAPP KI mice form abnormally large GC upon immunization, their GCB cells 
did not show an increased in rate of DNA synthesis as assessed by BrdU labelling. In contrast, 
survival of GCB cells is significantly increased in TAPP KI mice, suggesting that dysregulation 
of Akt in TAPP KI cells may manifest as increased cell survival, whereas cell division may be 
controlled by other signaling molecules. 
SHIP was found to be hyper-phosphorylated within GC B cells [20], likely via co-engagement of 
the BCR with Fc!RIIB by immune complexes within the GC environment. This high activity of 
SHIP within GCB cells may result in rapid conversion of the PIP3 generated by PI3K into 
PI(3,4)P2, leaving primarily the latter phosphoinositide available to drive Akt activation.  Binding 
of TAPP adaptors to PI(3,4)P2 may dampen Akt activation either by direct competition for this 
phosphoinositide, or by TAPP-mediated recruitment of other inhibitory molecules. TAPPs were 
reported to directly bind to the phosphatase PTPN13 (also known as PTPL1, FAP1 and PTP-BL), 
thus its possible that TAPPs regulate Akt via recruitment this phosphatase to the membrane [44]. 
TAPPs may additionally impact activity of PDK1, the upstream activating kinase for Akt, as PDK1 
also binds to and is activated by PI(3,4)P2 [45].  
A spectrum of chronic autoimmune diseases that includes SLE is associated with defective 
regulation of B cell activation and production of autoantibodies against DNA and nuclear proteins.  
Anti-DNA Abs frequently contain multiple somatic mutations, indicating their germinal center 
origin [40, 46]. Targeting B cells is an important strategy to improve treatment of SLE, however 
antibody-mediated B cell depletion or blockade of BAFF remain only marginally effective. 
Inhibition of B cell signaling pathways represents a new frontier beginning to be explored in 
autoimmune disease [47]. Consistent with findings in other mouse models, our results indicate that 
deregulation of the PI3K/Akt pathway can lead to aberrant GCs and SLE-like disease. These 
findings suggest that targeting of PI3Ks and/or Akt may represent viable therapeutic strategies for 
treatment of SLE.   
 
  
Materials and methods  
 
Mice and immunizations 
All animals were housed in a specific pathogen free facility at University of Manitoba, according 
to the Canadian Council on Animal Care guidelines. TAPP2R211L/R211L x TAPP2R218L/R218L (TAPP 
KI) mice contain mutations in the C-terminal PH domains of both TAPP1 and TAPP2 that abrogate 
their binding to the phosphoinositide PI(3,4)P2 as described [34]. p110"D910A/D910A (p110d) mice 
contain a kinase-inactivating mutation in PI 3-kinase delta as described [19].  TAPP KI mice were 
crossed with mice deficient ICOS-/- mice to generate ICOS-/- x TAPP2R211L/R211L x TAPP2R218L/R218L 
triple mutant (ICOS-/- x TAPP KI) mice. B cell deficient µMT mice and ICOS-/- mice were 
purchased from Jackson Laboratory. Mice were used for the experiments between 6-12 weeks of 
age except where otherwise specified. To assess the acute development of GC, mice were injected 
intraperitoneally (i.p) with 2x109 sheep red blood cells (Cedarlane # CL2581-100A) or 10 ug of 
NP-OVA (Biosearch Technologies) precipitated in 2 mg of alum (Imject, Pierce Biotechnology).   
 
Flow cytometry  
Spleens and mesenteric lymph nodes were homogenized to obtain single cell suspensions. RBCs 
were removed by using ACK lysis buffer. Cells were the filtered, re-suspended and counted to 
distribute 2 x 106 cells per FACS tube. Fc receptors were blocked by incubation with 2.4G2 
monoclonal antibody for 30 min on ice prior to surface staining with the indicated antibodies.  
Anti-B220(PercpCy5.5), anti-CD19(V450), anti-CD4(V500), anti-GL7(FITC), anti-FAS (PE-
Cy7), anti-CD80-APC, anti-CD86(APC), anti-Akt phospho-Ser308(PE), anti-PD1(biotin) and 
anti-ICOS(APC) were purchased from BD Biosciences or eBiosciences and diluted in FACS 
buffer (PBS containing 2% FCS). For intracellular staining of phosphor-Akt, splenocytes were 
surface stained, treated with fix/perm buffer (BD Biosciences) and then stained with anti-Akt 
phospho-Ser308.  Flow cytometry was performed using a BD FACS Canto II instrument. Data 
analyses were performed using FlowJo software.  
 
Assessment of germinal center responses 
For immunofluorescence microscopy analysis, spleens were harvested 14 days after NP-OVA 
immunization, embedded in O.C.T. compound (Tissue Tek) and snap frozen in liquid nitrogen. 
Frozen sections were fixed in ice cold acetone, blocked with 5% goat serum (30 min RT) and 
staining with biotinylated anti-IgD (2 hr RT), followed by streptavidin-Alexa 647, anti-GL7-FITC, 
and anti-CD4-PE (1hr RT).  All staining reagents were diluted in PBS+2% BSA.  Sections were 
imaged with an Ultraview LCI confocal microscope (Perkin-Elmer). The size of germinal centers 
were determined using image analysis software to calculate the relative areas of GL7+ IgD- regions. 
 
To measure in vivo DNA synthesis of germinal center B cells, mice were injected with 5 mg of 5-
bromo-2’-deoxyuridine (BrdU) (Sigma Aldrich) in PBS 5 hours before sacrifice. After cell surface 
staining of splenocytes as described above, cells were fixed and permeabilized on ice for 30 min 
using BD Cytofix/Cytoperm solution, followed by PBS+1% saponin for 10 minutes. Sample were 
then treated with deoxyribonuclease I solution (0.15M NaCl, 4.2 mM MgCl2, 10uM HCl, 50 
Kunitz units/ml DNase I) for 30 minutes at 37°C and stained with FITC labeled anti-BrdU antibody 
(eBioscience). Ex vivo apoptosis was determined by staining with Annexin V-FITC (Biovision) 
and DAPI (Invitrogen). Surface stained splenocytes were resuspended in Annexin V Binding 
Buffer (BD Pharmingen), and incubated with 1ul of Annexin V-FITC and 1ul DAPI (100ng/ul 
working solution) at RT for 10 minutes. Cells were then acquired immediately.  
 
ELISA 
Blood was collected by tail vein puncture or cardiac puncture and serum obtained after clotting 
centrifugation. For detection of total IgG and IgM, 96 well ELISA plates were coated with capture 
antibodies (Jackson ImmunoResearch) diluted in carbonate buffer (0.015M Na2CO3, 0.035 M 
NaHCO3, 0.05% NaN3, pH 9.6) overnight at 40C. After blocking with 2% BSA in washing buffer 
(PBS, 0.05% Tween 20, 0.02% NaN3, pH 7.4), incubation with diluted serum samples, and 
washing, bound antibodies were detected with biotinylated anti-mouse IgM or IgG antibodies 
(Southern Biotech). Antigen-specific antibodies binding to nitrophenyl (NP) were assayed by 
coating wells with NP3-BSA or NP20-BSA (Biosearch Technologies, Inc.) and detection with 
biotinylated antibodies specific for IgG1 (Southern Biotech).  Plates were developed by incubation 
with streptavidin alkaline phosphatase, washing, addition of p-nitrophenyl phosphate substrate 
(Sigma Aldrich). Molecular Devices plate reader was used to measure the absorbance at 405nm 
and 690nm. Anti-dsDNA IgG antibodies were measured using a kit from Alpha Diagnostics 
International, according to the manufacturers protocol.   
 
Anti-nuclear antibodies and IgG deposition in kidney 
Serum was obtained from peripheral blood of middle-aged mice after cardiac puncture. 
Antinuclear antibodies within the serum were detected by staining slides coated with HEp-2 cells 
(Biorad, cat# 26102).  Slides were blocked for one hour with normal horse serum, then serum 
samples diluted 1:40 were added and slides incubated for 2 hrs.  After washing with PBST (0.01% 
Tween in PBS), FITC tagged rabbit anti-mouse IgG secondary antibody (Life Technologies) was 
added at 1:2000 dilution. Slides were incubated for 30 mins, washed and mounted using ProLong 
Gold anti-fade reagent (Molecular Probes). To detect deposition of IgG within the kidney, freshly 
harvested kidneys were embedded in OCT and snap frozen in liquid nitrogen. 8 uM thick 
cryosections were prepared and stored at -80 C. Sections were fixed in cold acetone prior to 
staining with rabbit polyclonal anti mouse IgG at 1:2000 dilutions. For all staining procedures, 
antibodies were diluted in PBS containing 0.1% BSA and 0.01% Tween20.  Slides were imaged 
using a Zeiss AxioObserver spinning disk confocal microscope. 
Generation of bone marrow chimeras  
Bone marrow chimeras containing wild-type or TAPP KI B cells were generated as described [39]. 
Briefly, 6-8 week old uMT mice were lethally irradiated in a RS2000 irradiator (Rad Source 
Technologies), using two doses of 450 cGy separated by 2hr. Bone marrow (BM) harvested from 
4-6 week old WT or TAPP1/2 KI mice and the BM cells were mixed with uMT BM at a 1:4 ratio 
and used to reconstitute irradiated umT mice.  
Statistical analysis 
Statistical analysis was performed with GraphPad Prism software. P values were calculated using 
two-tailed unpaired student’s T test unless specified. Figures use the following representation for 
significance *P< 0.05, **P< 0.001, ***P< 0.0001 
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Figure Legends  
 
Figure 1.  TAPP1/2 KI mice develop chronic B cell activation and chronic GCs with age. 
A cohort of wild-type (WT) or TAPP2R211L/R211L x TAPP2R218L/R218L (TAPP KI) mice and 
p110"D910A/D910A (p110d) mice were examined at 28-30 weeks of age.  Splenocytes or mesenteric 
lymph node cells harvested from these mice and were analyzed by flow cytometry. (A) Splenic 
GL7+Fas+ germinal center B cells (GCB) were assessed as a percent of B220+ B cells (for gating 
details see Supplementary Fig. 1). Representative dot plots are shown at left and summary graph 
is shown on the right. (B) Splenic PD1+ ICOS+ TFH subsets were assessed as a percent of CD4+ T 
cells. Representative dot plots are shown at left and summary graph is shown on the right. (C) 
Expression of activation/memory markers CD80 and CD86 within splenic B220+ cells 
(representative histograms and gating shown in Supplementary Figure 2). (D) Frequencies of GCB 
cells, CD80 and CD86 expressing B cells within mesenteric lymph node were determined using 
the same method as for splenocytes. Data are pooled from two independent experiments totaling 
6-7 mice per group. TAPP KI versus WT statistical comparisons were performed by two tailed T-
test and significance is indicated as NS P>0.05, *P< 0.05, **P< 0.001, ***P< 0.0001.  
Figure 2. Development of chronic GC in TAPP KI mice is age and gene dose dependent    
Spleens were harvested from unimmunized young adult (8-12 wk), middle aged (28-30 wk) and 
old (42-45 wk) mice, and analyzed by flow cytometry. (A) Percentage of GCB cells in WT, TAPP 
KI and p110" KI mice in the indicated age groups. (B) Percentage of TFH population in the 
indicated age groups of WT, TAPP KI and p110" KI mice. (C) Effect of mutant TAPP1 and 
TAPP2 gene dose on GCB cell frequencies in young adult mice. (D) Effect of mutant TAPP gene 
dose on TFH frequencies in young adult mice.  (E) Age-dependent expression of CD80 in B cells. 
(F) Effect of mutant TAPP gene dose on CD80 expression in B cells from naïve young adults. 
Graphs A, B and E represent the mean and standard error of 3-7 mice per time point pooled from 
2 independent experiments, and statistical comparisons between TAPP KI versus WT were 
performed by two-way ANOVA. Graphs C, D and F represent the mean and standard error of 3-7 
mice per genotype pooled from 3 independent experiments, and statistical comparisons between 
homozygous TAPP KI and the indicated heterozygous genotypes or were performed by two-tailed 
T-test.  Significance is indicated as NS P>0.05, *P< 0.05, **P< 0.001, ***P< 0.0001. 
Figure 3. Increased GC size generated upon immunization of young adult TAPP KI mice.   
Young adult WT or TAPP KI mice (8-12 weeks of age) were immunized with sheep red blood 
cells (SRBC) or with nitrophenyl-ovalbumin precipitated in alum (NP-OVA/alum) and analyzed 
8 or 10 days later respectively. (A) Spleens were harvested and the frequency of GL7+FAS+ 
germinal center B cells (GCB) determined by flow cytometry. Bar graph shows GCB frequencies 
as a percent of total B cells, with GCB-deficient p110"D910A/D910A (p110d) mice used as controls. 
Results are from a single experiment with 4 mice per group and are representative of 3 similar 
experiments.  (B) Spleen cryosections from NP-OVA/alum-immunized mice were stained to detect 
GL7+IgD- GCs by confocal microscopy. Graph shows the relative area of GCs pooled from 3 mice 
per genotype.  Each dot represents pixel count for a region of interest encompassing one GC. Scale 
bars, 200 µm.  (C) The PD1+ICOS+ TFH population was assessed in SRBC immunized mice. Graph 
displays the percentage of TFH cells among CD4+ T cells from individual mice of the indicated 
genotypes.  Data are pooled from 2 experiments, each with 3 WT and TAPP KI mice.  (D) Sera 
were collected from NP-OVA/alum immunized mice at day 14, 21, 28 and 35 and analyzed by 
ELISA for binding to NP3-BSA or NP20-BSA to detect high and low affinity antigen-specific 
antibody respectively. Graph shows the ratio of NP3/NP20 binding IgG Ab over time after 
immunization. (E) Total IgG antibody levels from the same immunized mice as in D.  TAPP KI 
versus WT statistical comparisons were performed by two tailed T-test (A-C) or two-way ANOVA 
(E) and significance is indicated as *P< 0.05, **P< 0.001, ***P< 0.0001. 
Figure 4. TAPP KI GC B cells show normal proliferation but increased Akt phosphorylation 
and survival 
(A) Splenocytes were surface stained, fixed, permeabilized and intracellularly stained with anti-
phosphoAkt. Histograms of anti-phosphoAkt staining within the GCB population are shown for 
two representative TAPP KI or WT mice from the same experiment. The right panel shows average 
anti-phosphoAkt mean fluorescence intensity (MFI) within GCB or non-GCB populations, pooled 
from 2 experiments with 3 mice per experiment.  (B) OVA/alum-immunized mice were injected 
with BrdU five hours before sacrifice on day 14. Cells were then surface-stained, fixed, 
permeabilized and then intracellularly stained with anti-BrdU to determine BrdU incorporation 
within the GCB and non-GCB populations by flow cytometry. (C) To assess cell survival ex vivo, 
the frequency of annexin V and DAPI negative cells among GCB and non-GCB populations was 
determined by flow cytometry. The AnnexinV/DAPI density plots are representative of 2 
experiments each with 3 mice per group.  The graph on the right shows the frequencies of annexinV 
and DAPI negative cells among GCB from individual WT and TAPP KI mice at the indicated time 
points after immunization. All data show representative experiments containing at least 3 mice per 
group. TAPP KI versus WT statistical comparisons were performed using 2-tailed T-test and 
significance is indicated as NS P>0.05, *P< 0.05, **P< 0.001, ***P< 0.0001. 
Figure 5. Ablation of GCs blocks development of autoantibodies in TAPP KI mice.  
 (A) Young adult mice TAPP KI or ICOS -/- x TAPP KI mice were immunized with sheep red 
blood cells and analyzed for B220+GL7+FAS+ GCB cells at day 8 by flow cytometry. Results are 
pooled from 2 experiments, each with 3 mice per genotype. (B) Middle aged TAPP KI or ICOS -
/- TAPP KI mice were analyzed for chronic GCB. (C, D) Expression of CD80 and CD86. Results 
in B-D are pooled from 3 experiments, totaling 3-5 mice per genotype. TAPP KI versus ICOS -/- 
x TAPP KI statistical comparisons were performed using two tailed T-test and significance is 
indicated as **P< 0.001, ***P< 0.0001. (E, F) Sera collected from mice at the indicated age were 
tested by ELISA for (E) anti-double stranded DNA IgG or (F) anti-double stranded DNA IgM. 
Results are pooled from 3-4 mice per genotype each undergoing multiple serum collections at the 
indicated time points. TAPP KI versus ICOS -/- x TAPP KI statistical comparisons were performed 
using 2-way ANOVA and significance is indicated as *P< 0.05, ***P< 0.0001.  (G) Sera obtained 
from middle aged mice were tested for anti-nuclear antibodies by immunofluorescence staining of 
HEp2 cells. Images are representative of 3 mice tested per genotype.  (H) Kidney cryosections 
from middle aged mice were stained for IgG antibody to detect immune complex deposition in 
glomeruli. Images are representative of 3 mice tested per genotype. Scale bars, 20 µm. 
Figure 6. TAPP KI B cells can drive the development of autoimmunity 
Irradiated B cell-deficient (µmT) mice were reconstituted with a mixture of either TAPP KI or WT 
bone marrow and µmT bone marrow at a 1:4 ratio. Blood cells were collected from recipient µmT 
mice at 6 weeks post-reconstitution and then analyzed by flow cytometry to determine (A) 
reconstitution of B cells and (B) B-cell expression of CD80 and CD86 (right). (C) At 25 weeks 
post-reconstitution, splenic B cells from these mice were analyzed for GCB, CD80+ and CD86+ 
B-cell populations (left) and Tfh cells (right). (D) Sera from B cell reconstituted mice were 
collected at 15, 20 and 25 weeks and tested by ELISA for anti-dsDNA IgG antibody. (E) At 25 
weeks post-reconstitution, sera were tested for anti-nuclear antibody by immunofluorescence 
staining of HEp2 cells.  (F) At 25 weeks post-reconstitution, kidney sections were tested for IgG 
immune complex deposition.  Images in E and F are representative of 3 mice tested per group.  
Graphs A-D are results pooled from 2 experiments, each with 3 mice.  TAPP KI versus WT 
statistical comparisons were performed by two tailed T-test (A-C) or two-way ANOVA (D) and 
significance is indicated as NS P>0.05, *P< 0.05, **P< 0.001, ***P< 0.0001.  
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Supplementary	Figure	1.		Strategy	for	gating	germinal	center	B	cells.
An	example	of	splenocytes stained	for	B220,	CD4,	GL7	and	Fas is	shown.		Two	steps	of	
scatter	gating		were	used	as	illustrated	to	remove	doublets,	high	side	scatter	granulocytes	
and	dead	cells	from	the	analysis.		The	third	and	fourth	gates	were	used	to	identify	total	
B220+CD4- B	cells	and	GL7+Fas+	germinal	center	B	cells.		In	all	data	figures,	germinal	
center	B	cells	(GCB)	are	expressed	as	the	percent	of	the	total	B220+	B	cells.
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Supplementary	Figure	2.		Increased	CD80	and	CD86	expression	on	B	
cells	from	TAPP	KI	mice.
Histograms	show	expression	of	CD80	or	CD86	on	B220+	splenic	B	cells	from	representative	
wild-type	C57BL6	(WT),	TAPP2R211L/R211L	x	TAPP2R218L/R218L (TAPP	KI)	or	p110dD910A/D910A
(P110d)	mice.		Summary	graph	indicating	the	percent	CD80+	or	CD86+	from	multiple	mice	
per	group	is	presented	in	Figure	1C.
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Supplementary	Figure	3.	Additional	microscopy	images	comparing	
wild-type	and	TAPP	KI	GC.
Mice	were	immunized	with	NP-OVA	precipitated	in	alum	and	spleens	collected	at	day	8.	
Cryosections were	stained	for	specific	markers	to	detect	GC	B	cells	relative	to	IgD+	non-
GCB	cells	and	CD4+	T	cells	(top	panels),	FDC-M2+	follicular	dendritic	cells	(middle	panels),	
or	to	detect	Ki67+	proliferating	cells	within	IgD-negative	GC	(bottom	panels)	and.		Scale	
bars,	100	µm.
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